Clinical Trial

A Population-based Cohort in Northern Spain

Study acronym: COHORTE
Recruiting
View on ClinicalTrials.gov →
Summary
Cantabria Cohort stems from a research and action initiative lead by researchers from Valdecilla Research Institute (IDIVAL), Marqués de Valdecilla University Hospital and University of Cantabria, supported by the regional Goverment. Its aim is to identify and follow up a cohort that would provide information to improve the understanding of the etiology and prognosis of different acute and chronic diseases. The Cantabria Cohort will recruit between 40,000-50,000 residents aged 40-69 years at baseline, representing 10-20% of the target population. Currently, more than 22,000 volunteers have been enrolled. All participants will be invited for a re-assessment every three years, while the overall duration is planned for twenty years. The repeated collection of biomaterials combined with broad information from participant questionnaires, medical examinations, actual health system records and other secondary public data sources is a major strength of its design, which will make it possible to address biological pathways of disease development, identify new factors involved in health and disease, design new strategies for disease prevention, and advance precision medicine. It is conceived to allow access to a large number of researchers worldwide to boost collaboration and medical research.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-05-02.
Trial Details
NCT Number NCT05852678
Lead Sponsor Instituto de Investigación Marqués de Valdecilla
Conditions Chronic Disease
Enrollment 22,000 participants
Start Date 2021-04-20
Primary Completion 2045-04-01 (estimated)
Study Completion 2045-04-01 (estimated)
Updated on ClinicalTrials.gov 2023-05-12